Ready-Made immune cells tested to fight tough blood cancers
NCT ID NCT06552416
Summary
This early-stage study is testing a new type of treatment called MT-401-OTS, which uses specially prepared immune cells from healthy donors to fight cancer. It is for adults aged 65+ with certain types of relapsed acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) who still have some disease after standard treatment. The main goals are to find a safe dose and see if the therapy can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center)
RECRUITINGDuarte, California, 91006, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
KU Cancer Center
RECRUITINGKansas City, Kansas, 66160, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.